We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+7.95%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$225M
AUM Growth
+$15.2M
Cap. Flow
-$414K
Cap. Flow %
-0.18%
Top 10 Hldgs %
37.39%
Holding
60
New
2
Increased
9
Reduced
31
Closed
1

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$4.51M
2
NVST icon
Envista
NVST
+$3.84M
3
MHK icon
Mohawk Industries
MHK
+$788K
4
BDX icon
Becton Dickinson
BDX
+$638K
5
PTC icon
PTC
PTC
+$309K

Top Sells

Rank Stock Value
1
MIDD icon
Middleby
MIDD
+$2.95M
2
HEI icon
HEICO Corp
HEI
+$708K
3
GLW icon
Corning
GLW
+$689K
4
MKC icon
McCormick & Company Non-Voting
MKC
+$670K
5
WAB icon
Wabtec
WAB
+$590K

Sector Composition

Rank Sector Weight
1 Healthcare 28.74%
2 Technology 26.47%
3 Industrials 17.24%
4 Materials 15.19%
5 Communication Services 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
1
Martin Marietta Materials
MLM
$31.5B
$10M 4.45%
35,795
-1,000
-3% -$267K
ADSK icon
2
Autodesk
ADSK
$49.5B
$9.13M 4.06%
49,774
-1,200
-2% -$194K
BDX icon
3
Becton Dickinson
BDX
$45.6B
$9.01M 4.01%
33,973
+2,558
+8% +$638K
INFO
4
DELISTED
IHS Markit Ltd. Common Shares
INFO
$8.97M 3.98%
119,009
-2,800
-2% -$199K
EW icon
5
Edwards Lifesciences
EW
$49.6B
$8.71M 3.87%
111,975
-4,275
-4% -$334K
HEI icon
6
HEICO Corp
HEI
$49.8B
$8.05M 3.58%
70,504
-5,752
-8% -$708K
LIN icon
7
Linde
LIN
$221B
$7.74M 3.44%
36,339
+22,400
+161% +$4.51M
ROP icon
8
Roper Technologies
ROP
$38.8B
$7.59M 3.37%
21,413
-900
-4% -$311K
TMO icon
9
Thermo Fisher Scientific
TMO
$213B
$7.47M 3.32%
23,010
-960
-4% -$291K
DHR icon
10
Danaher
DHR
$137B
$7.46M 3.32%
54,861
-1,410
-3% -$178K
TECH icon
11
Bio-Techne
TECH
$11.2B
$7.21M 3.2%
131,288
-4,100
-3% -$215K
FISV
12
Fiserv Inc
FISV
$28.8B
$6.77M 3.01%
58,550
-3,850
-6% -$425K
EPAM icon
13
EPAM Systems
EPAM
$5.51B
$6.61M 2.94%
31,165
-1,900
-6% -$374K
TFX icon
14
Teleflex
TFX
$6.05B
$6.29M 2.79%
16,695
-500
-3% -$172K
MKC icon
15
McCormick & Company Non-Voting
MKC
$13.7B
$6.28M 2.79%
74,000
-8,100
-10% -$670K
IFF icon
16
International Flavors & Fragrances
IFF
$20.2B
$6.27M 2.79%
48,600
-2,150
-4% -$275K
ANSS
17
DELISTED
Ansys
ANSS
$6.24M 2.77%
24,225
-1,600
-6% -$378K
WWD icon
18
Woodward
WWD
$21.3B
$5.5M 2.44%
46,400
-2,750
-6% -$310K
LII icon
19
Lennox International
LII
$14.4B
$4.96M 2.21%
20,350
-1,450
-7% -$360K
IT icon
20
Gartner
IT
$10.1B
$4.85M 2.15%
31,450
-1,050
-3% -$160K
EMR icon
21
Emerson Electric
EMR
$83.9B
$4.81M 2.14%
63,087
-3,299
-5% -$238K
PAYX icon
22
Paychex
PAYX
$41.6B
$4.75M 2.11%
55,862
-1,700
-3% -$143K
XYL icon
23
Xylem
XYL
$27.3B
$4.67M 2.07%
59,220
+1,100
+2% +$85.6K
RVTY icon
24
Revvity
RVTY
$12.6B
$4.61M 2.05%
47,500
-1,550
-3% -$138K
XRAY icon
25
Dentsply Sirona
XRAY
$2.68B
$4.43M 1.97%
78,375
+600
+0.8% +$33.5K

Similar funds

Stone Run Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Stone Run Capital held 60 positions worth $225M, up 7.2% from $210M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Stone Run Capital's Q4 2019 filing shows 2 new, 9 increased, 31 reduced and 1 closed positions. Its largest new stake was Envista: 134,900 shares worth $4M. The largest sale was Middleby, an estimated $2.95M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • Stone Run Capital's largest Q4 2019 buy was Envista: 134,900 shares worth $4M.
  • Stone Run Capital added most to Linde in Q4 2019, an estimated $4.51M increase.
  • Stone Run Capital's biggest Q4 2019 reduction was HEICO Corp, cutting an estimated $708K.
  • Stone Run Capital fully exited Middleby in Q4 2019, selling an estimated $2.95M.
  • Stone Run Capital's ten largest holdings make up 37% of its $225M portfolio in Q4 2019.
  • Stone Run Capital opened 2 new positions and closed 1 in Q4 2019.
  • Stone Run Capital's portfolio value rose 7.2% quarter-over-quarter to $225M.

Based on Stone Run Capital's 13F filing for Q4 2019, filed 14 Feb 2020.